French Cohort on Neonatal Cerebral Artery Infarction

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Infant, Newborn (birth to 28 days)","concept":{"vocab":"MeSH","vocabURI":"D007231"}},{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"All participating newborns hospitalised by neonatal and paediatric neurology services. Full-term newborns presenting perinatal arterial ischaemic stroke were included i.e.: - presenting neurological symptoms (convulsions, malaise, hypotonia, impaired vigilance, asymmetric tone or motor skills) in the first 28 days of life; - Brain imaging (by CT or MRI scan) showing appearance of ischaemic-like lesions in an arterial location; - parents or those with parental authority who gave their consent after explanation of the protocol aims and modalities by the local investigating party and who received an explanatory document.","clusion_E":"premature births; - asymptomatic neonates i.e. systematic discovery of an immediate pre- or post-natal image abnormality or children presenting with aposteriori cerebral palsy; - children with diffuse hypoxic-ischaemic lesions i.e more than three affected arterial territories or venous infarction; - where clinical and biological follow-up is impossible; - parental refusal to be included in the study or refusal to sign molecular biology consent form."}